Search Result "antiparkinsonian activity"
The Use of Antiparkinsonian Agents in the Management of Drug-Induced Extrapyramidal Symptoms
Journal: Current Pharmaceutical Design
Volume: 10 Issue: 1 Year: 2004 Page: 2239-2248
Author(s): K. Burgyone, K. Aduri, J. Ananth, S. Parameswaran
Parkinson Disease and Antiparkinsonian Drugs
Ebook: Medicinal Chemistry for Pharmacy Students
Volume: 2 Year: 2020
Author(s): Ashok E. Philip,George DeMaagd,M. O. Faruk Khan
Doi: 10.2174/9789811454073120020010
3-Methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2-diol: the Importance of Functional Groups for Antiparkinsonian Activity
Journal: Medicinal Chemistry
Volume: 9 Issue: 5 Year: 2013 Page: 731-739
Author(s): Oleg V. Ardashov,Alla V. Pavlova,Dina V. Korchagina,Konstantin P. Volcho,Tat’ yana G. Tolstikova,Nariman F. Salakhutdinov
Antiparkinsonian Potential of Natural Products: Molecular Docking,Prediction of Pharmacokinetic and Toxicological Properties
Journal: Current Physical Chemistry
Volume: 13 Issue: 1 Year: 2023 Page: 75-89
Author(s): Henrique B. Lima,Jaderson V. Ferreira,Mariela L. Nery,Gisele A. Chaves,Anderson L. P. da Costa,Lucilene R. de Souza,Bianca L. Marino,Maiara F.B. Brito,Hueldem R.C. Teixeira,Carlos H.T.P. Silva,Carlton A. Taft,Lorane I.S. Hage-Melim
Medicinal Plants and Natural Compounds as Antiparkinsonian Agents
Ebook: Neurodegenerative Diseases: Multifactorial Degenerative Processes, Biomarkers and Therapeutic Approaches (First Edition)
Volume: 1 Year: 2022
Author(s): Saumitra Sen Singh,Aaina Singh Rathore,Priyanka Kumari Keshri,Surya Pratap Singh
Doi: 10.2174/9789815040913122010014
Piribedil: Antiparkinsonian Properties and Potential Clinical Utility in Dopaminergic Disorders
Journal: Current Drug Therapy
Volume: 6 Issue: 1 Year: 2011 Page: 17-34
Author(s): Aravind Mittur
Synthesis and Antimicrobial Activity of Adamantyl Substituted Pyridoxine Derivatives
Journal: Letters in Drug Design & Discovery
Volume: 16 Issue: 12 Year: 2019 Page: 1360-1369
Author(s): Rail Khaziev,Nikita Shtyrlin,Roman Pavelyev,Raushan Nigmatullin,Raylya Gabbasova,Denis Grishaev,Anna Shtro,Anastasia Galochkina,Yulia Nikolaeva,Tatiana Vinogradova,Olga Manicheva,Marine Dogonadze,Oleg Gnezdilov,Evgenii Sokolovich,Petr Yablonskiy,Konstantin Balakin,Yurii Shtyrlin
A New Series of 1,3-Dimethylxanthine Based Adenosine A2A Receptor Antagonists as a Non-Dopaminergic Treatment of Parkinsonâs Disease
Journal: Current Drug Discovery Technologies
Volume: 18 Issue: 5 Year: 2021 Page: 3-13
Author(s): Suman Rohilla,Ranju Bansal,Puneet Chauhan,Sonja Kachler,Karl-Norbert Klotz
Different Generations of Type-B Monoamine Oxidase Inhibitors in Parkinsonâs Disease: From Bench to Bedside
Journal: Current Neuropharmacology
Volume: 17 Issue: 9 Year: 2019 Page: 861-873
Author(s): Marika Alborghetti,Ferdinando Nicoletti
Current Status of Tyrosine Hydroxylase in Management of Parkinsonâs Disease
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11 Issue: 4 Year: 2012 Page: 450-455
Author(s): Annaik Petithomme Feve